Brief: Elicera Therapeutics Q4 Oper Loss Narrows To SEK 2.9 Mln
03/02/2025 07:18
Feb 3 (Reuters) - Elicera Therapeutics AB ELIC.ST :
* Q4 LOSS FOR PERIOD AMOUNTED TO SEK -2,603,242 (-4,749,222)
* Q4 OPERATING LOSS AMOUNTED TO SEK -2,911,958 (-5,212,694)
Source text: ID:nWkr2rsldY
Further company coverage: ELIC.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Elicera Therapeutics AB
See all newsBrief: Nomination Committee Proposes Margareth Jorvid As Chair Of Elicera Board
Brief: Elicera Therapeutics Carries Out Rights Issue Of About SEK 73 Mln
Sweden's Elicera Therapeutics Q1 loss narrows, reports positive clinical progress
Brief: Elicera Therapeutics Q1 Operating Loss SEK 5.1 Mln
Brief: Elicera Therapeutics Gets Notice Of Allowance For Japanease Patent